Literature DB >> 32551162

The role of positron emission tomography/computed tomography in the evaluation of anterior mediastinal masses and differentiating between the histological subtypes of thymic epithelial neoplasms.

Ahmet Yanarateş1, Emine Budak1.   

Abstract

BACKGROUND: This study aims to investigate the role of positron emission tomography/computed tomography in differentiating between benign and malignant anterior mediastinal masses and between the histological subtypes of thymic epithelial neoplasms.
METHODS: This retrospective study included a total of 57 patients (30 males, 27 females; mean age 48.9 years; range, 14 to 78 years) who underwent an fluorodeoxyglucose positron emission tomography/ computed tomography with an indication of an anterior mediastinal mass between May 2010 and November 2018. The maximum and mean standardized uptake values, metabolic tumor volume, total lesion glycolysis, and mean Hounsfield units of the lesions were determined. Thymic epithelial neoplasms were classified as low-risk thymomas (A, AB, B1), high-risk thymomas (B2, B3), and thymic carcinomas. All lesions were evaluated together and divided into two groups as benign and malignant, and positron emission tomography/computed tomography parameters of the two groups were compared.
RESULTS: Histopathological examination identified 29 thymic epithelial neoplasms (13 low-risk, 14 high-risk, two thymic carcinomas), 13 benign lesions, and 15 malignant lesions. No significant correlation was identified between the positron emission tomography/computed tomography parameters and histological subtype of thymic epithelial neoplasms. There was no significant difference in the maximum and mean standardized uptake values, metabolic tumor volume, total lesion glycolysis, and mean Hounsfield units of the lesions between low-risk and high-risk thymic carcinomas. The maximum and mean standardized uptake values, metabolic tumor volume, and mean Hounsfield units of the lesions were significantly higher in the malignant group than in the benign group.
CONCLUSION: Our study results show that positron emission tomography/ computed tomography is useful in the differentiation of benign and malignant anterior mediastinal masses, although it fails to differentiate between the histological subtypes of thymic epithelial neoplasms.
Copyright © 2020, Turkish Society of Cardiovascular Surgery.

Entities:  

Keywords:  Anterior mediastinal mass; fluorodeoxyglucose; maximum standardized uptake value; metabolic tumor volume; positron emission tomography/computed tomography; thymic epithelial neoplasm

Year:  2020        PMID: 32551162      PMCID: PMC7298385          DOI: 10.5606/tgkdc.dergisi.2020.18432

Source DB:  PubMed          Journal:  Turk Gogus Kalp Damar Cerrahisi Derg        ISSN: 1301-5680            Impact factor:   0.332


  24 in total

1.  Primary cysts and neoplasms of the mediastinum: recent changes in clinical presentation, methods of diagnosis, management, and results.

Authors:  R D Davis; H N Oldham; D C Sabiston
Journal:  Ann Thorac Surg       Date:  1987-09       Impact factor: 4.330

2.  [18F]FDG positron emission tomography/computed tomography and multidetector computed tomography roles in thymic lesion treatment planning.

Authors:  Laura L Travaini; Giuseppe Petralia; Giuseppe Trifirò; Laura Ravasi; Domenico Galetta; Giuseppe Carbone; Fabio Falcini; Lorenzo Spaggiari; Massimo Bellomi; Giovanni Paganelli
Journal:  Lung Cancer       Date:  2008-03-20       Impact factor: 5.705

Review 3.  A diagnostic approach to mediastinal abnormalities.

Authors:  Camilla R Whitten; Sameer Khan; Graham J Munneke; Sisa Grubnic
Journal:  Radiographics       Date:  2007 May-Jun       Impact factor: 5.333

4.  (18)F-FDG PET for the evaluation of thymic epithelial tumors: Correlation with the World Health Organization classification in addition to dual-time-point imaging.

Authors:  Atsuo Inoue; Noriyuki Tomiyama; Mitsuaki Tatsumi; Naoki Ikeda; Meinoshin Okumura; Hiroyuki Shiono; Masayoshi Inoue; Ichiro Higuchi; Katsuyuki Aozasa; Takeshi Johkoh; Hironobu Nakamura; Jun Hatazawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-14       Impact factor: 9.236

5.  18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups.

Authors:  Yon Mi Sung; Kyung Soo Lee; Byung-Tae Kim; Joon Young Choi; Young Mog Shim; Chin A Yi
Journal:  J Nucl Med       Date:  2006-10       Impact factor: 10.057

6.  Magnetic resonance imaging of the mediastinum.

Authors:  K M Link; L J Samuels; J C Reed; S P Loehr; N M Lesko
Journal:  J Thorac Imaging       Date:  1993       Impact factor: 3.000

7.  Usefulness of [18F]fluoro-2-deoxy-D-glucose positron emission tomography for predicting the World Health Organization malignancy grade of thymic epithelial tumors.

Authors:  Hitoshi Igai; Natsumi Matsuura; Shintaro Tarumi; Sung Soo Chang; Noriyuki Misaki; Tetsuhiko Go; Shinya Ishikawa; Hiroyasu Yokomise
Journal:  Eur J Cardiothorac Surg       Date:  2010-10-15       Impact factor: 4.191

8.  Anterior mediastinal tumors: diagnostic accuracy of CT and MRI.

Authors:  Noriyuki Tomiyama; Osamu Honda; Mitsuko Tsubamoto; Atsuo Inoue; Hiromitsu Sumikawa; Keiko Kuriyama; Masahiko Kusumoto; Takeshi Johkoh; Hironobu Nakamura
Journal:  Eur J Radiol       Date:  2007-11-26       Impact factor: 3.528

9.  Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors.

Authors:  Masahiro Endo; Kazuo Nakagawa; Yasuhisa Ohde; Takehiro Okumura; Haruhiko Kondo; Satoshi Igawa; Yukiko Nakamura; Asuka Tsuya; Haruyasu Murakami; Toshiaki Takahashi; Nobuyuki Yamamoto; Ichiro Ito; Toru Kameya
Journal:  Lung Cancer       Date:  2008-03-04       Impact factor: 5.705

10.  Primary cysts and tumors of the mediastinum.

Authors:  A J Cohen; L Thompson; F H Edwards; R F Bellamy
Journal:  Ann Thorac Surg       Date:  1991-03       Impact factor: 4.330

View more
  1 in total

1.  Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center.

Authors:  Naziye Ak; Alper Toker; Murat Kara; Berker Özkan; Melike Ülker; Erkan Kaba; Gülçin Yeğen; Şule Karaman; Nergiz Dağoğlu; Esra Kaytan Sağlam; Ethem Nezih Oral; Ahmet Kızır; Soley Bayraktar; Rian Dişçi; Ferhat Ferhatoğlu; Esra Aydın; Sezai Vatansever; Yeşim Eralp; Adnan Aydıner
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-10-20       Impact factor: 0.332

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.